BRIEF-RB Global Announces Executive Leadership Appointments And Organizational Updates To Support Next Phase Of Growth And Industry Leadership
Reuters2026/10/08 12:33RB Global, Inc (Ontario) RBA.TO: RB GLOBAL ANNOUNCES EXECUTIVE LEADERSHIP APPOINTMENTS AND ORGANIZATIONAL UPDATES TO SUPPORT NEXT PHASE OF GROWTH AND INDUSTRY LEADERSHIP RB GLOBAL- PROMOTES STEVE STEINBERG TO CHIEF FINANCIAL OFFICER RB GLOBAL - ERIC GUERIN AND STEVE LEWIS TO DEPART AS CFO AND COO RB GLOBAL - EXPECTS FY2026 FINANCIAL RESULTS AT HIGH END OF OUTLOOK RANGE PROVIDED ON AUGUST 4 Source text: ID:nBwbJR1l9a Further company coverage: RBA.TO
RB Global, Inc (Ontario) RBA.TO:
RB GLOBAL ANNOUNCES EXECUTIVE LEADERSHIP APPOINTMENTS AND ORGANIZATIONAL UPDATES TO SUPPORT NEXT PHASE OF GROWTH AND INDUSTRY LEADERSHIP
RB GLOBAL- PROMOTES STEVE STEINBERG TO CHIEF FINANCIAL OFFICER
RB GLOBAL - ERIC GUERIN AND STEVE LEWIS TO DEPART AS CFO AND COO
RB GLOBAL - EXPECTS FY2026 FINANCIAL RESULTS AT HIGH END OF OUTLOOK RANGE PROVIDED ON AUGUST 4
Source text: ID:nBwbJR1l9a
Further company coverage: RBA.TO
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
